Harbor Capital Advisors, Inc. Haemonetics Corp Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 28,633 shares of HAE stock, worth $1.5 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
28,633
Previous 34,532
17.08%
Holding current value
$1.5 Million
Previous $2.2 Million
2.69%
% of portfolio
0.09%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
54MCall Options Held
637KPut Options Held
300K-
Black Rock Inc. New York, NY5.96MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$259 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$223 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$137 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$115 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.68B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...